OK-432 (Picibanil) sclerotherapy for recurrent dislocation of the temporomandibular joint in elderly edentulous patients: Case reports

Matsushita, Kazuhiro; Abe, Takuzo; Fujiwara, Toshikatsu

doi:10.1016/j.bjoms.2006.09.002

Cited by 23 publications

(16 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…(Fig. 6) Non-surgical methods have also been used in the management of recurrent TMJ dislocation to prevent future dislocation, including autologous blood injection, injection of botulinum toxin A and Picibanil (Chugai Pharmaceutical Co., Ltd., Tokyo, Japan) injection27,33.…”

Section: Discussionmentioning

confidence: 99%

Temporomandibular joint dislocation: experiences from Zaria, Nigeria

Agbara

Fomete

Obiadazie

et al. 2014

J Korean Assoc Oral Maxillofac Surg

View full text Add to dashboard Cite

ObjectivesDislocation of the temporomandibular joint may occur for various reasons. Although different invasive methods have been advocated for its treatment, this study highlights the value of non-invasive treatment options even in chronic cases in a resource-poor environment.Materials and MethodsA seven-year retrospective analysis of all patients managed for temporomandibular joint dislocation in our department was undertaken. Patient demographics, risk factors associated with temporomandibular joint dislocation and treatment modalities were retrieved from patient records.ResultsIn all, 26 patients were managed over a seven-year period. Males accounted for 62% of the patients, and yawning was the most frequent etiological factor. Conservative treatment methods were used successfully in 86.4% of the patients managed. Two (66.7%) of the three patients who needed surgical treatment developed complications, while only one (5.3%) patient who was managed conservatively developed complications.ConclusionTemporomandibular joint dislocation appears to be associated with male sex, middle age, yawning, and low socio-economic status, although these observed relationships were not statistically significant. Non-invasive methods remain an effective treatment option in this environment in view of the low socio-economic status of the patients affected.

show abstract

Section: Discussionmentioning

confidence: 99%

Temporomandibular joint dislocation: experiences from Zaria, Nigeria

Agbara

Fomete

Obiadazie

et al. 2014

J Korean Assoc Oral Maxillofac Surg

View full text Add to dashboard Cite

show abstract

“…The aim of this approach is to promote fibrosis of the capsular tissue and consequent motion restraint of mandibular excursion. 9,10 The procedure presents advantages such as ease of performance, low cost, a low complication rate, and greater patient compliance when compared to more invasive alternatives.…”

mentioning

confidence: 99%

Autologous blood injection for the treatment of recurrent mandibular dislocation

Coser

Silveira

Medeiros

et al. 2015

International Journal of Oral and Maxillofacial Surgery

View full text Add to dashboard Cite

“…Minimally invasive methods include injections of sclerosing agents intra-articularly and extra-capsularly or injections of botulinum toxin to the surrounding muscles (13)(14)(15).…”

Section: Introductionmentioning

confidence: 99%

Comparative Study Between 2 Types of Prolotherapy in Treatment of Chronic Recurrent Temporomandibular Joint Dislocation

Khamis

Osman

Mohamed

2019

Alexandria Dental Journal

View full text Add to dashboard Cite

INTRODUCTION:Temporomandibular Joint (TMJ) dislocation when condyles travel anterior to articular eminence. It may be reducible or irreducible. Chronic recurrent TMJ dislocation was treated by surgical and nonsurgical methods. Minimally invasive methods include injection of sclerosing agents intra-articular and extra-capsular or botulinum toxin to the surrounding muscles. Prolotherapy is a method of strengthening lax ligaments by injecting various types of sclerosing or proliferant solutions such as ethanolamine oleate 5%, autologus blood and others. It is also known as "ligament sclerotherapy" or "regenerative injection therapy" OBJECTIVES: the study aimed to compare 2 types of prolotherapy (autologous blood & ethanolamine Oleate sclerosing agent) injection in treatment of chronic recurrent temporomandibular joint dislocation. . Thirty patients with chronic recurrent temporomandibular joint dislocation were chosen with certain inclusion and exclusion criteria. Fifteen participants were injected with ethanolamine oleate compared with fifteen patients were injected with autologous blood and were followed-up for six months. The participated patients were assessed at the pre-and post-treatment stages by evaluating pain and mandibular range of motion clinically and radiographically using Magnatic Resonance Imaging (MRI) to evaluate condyle-articular eminence relation in opening and closing mouth. RESULTS: There was no significant difference between both prolotherapies in treating chronic recurrent temporomandibular joint dislocation. CONCLUSIONS: Ethanolamine oleate and autologus blood injection are simple, safe and cost-effective treatment for management of chronic recurrent temporomandibular joint dislocation.

show abstract

OK-432 (Picibanil) sclerotherapy for recurrent dislocation of the temporomandibular joint in elderly edentulous patients: Case reports

Cited by 23 publications

References 7 publications

Temporomandibular joint dislocation: experiences from Zaria, Nigeria

Temporomandibular joint dislocation: experiences from Zaria, Nigeria

Autologous blood injection for the treatment of recurrent mandibular dislocation

Comparative Study Between 2 Types of Prolotherapy in Treatment of Chronic Recurrent Temporomandibular Joint Dislocation

Contact Info

Product

Resources

About